2014
DOI: 10.5505/agri.2014.47550
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Intravenous Dexketoprofen Use on Postoperative Analgesic Consumption in Patients with Lumbar Disc Surgery

Abstract: ÖzetAmaç: Bu çalışmanın amacı, lomber mikrodiskektomi uygulanan olgularda preemptif intravenöz tek doz uygulanan deksketoprofenin ameliyat sonrası analjezik etkisini araştırmaktır. Gereç ve Yöntem: Bu çalışmaya laminektomi ameliyatı olacak ASA I-II toplam 50 olgu alındı. Olgular iki gruba ayrıldı. Ameliyat başlamadan 10 dakika önce, verilen ilacın içeriğini bilmeyen anestezi hekimi tarafından, Grup A' daki olgulara 50 mg (2 ml) deksketoprofen, Grup K' daki olgulara ise 2 ml serum fizyolojik intravenöz olarak v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 12 publications
1
8
0
2
Order By: Relevance
“…of DEX (Eroglu, Durmus, & Kiresi, ; Esparza‐Villalpando et al, ; Iohom, Walsh, Higgins, & Shorten, ; Kara, Tuncer, Erol, & Reisli, ; Kesimci, Gümüs, & Kanbak, ), while the other studies employed intravenous (i.v.) administration (Atalay, Dogan, & Kizilkaya, ; Bolat, Erhan, & Deniz, ; Çağiran, Eyigör, & Sezer, ; Gelir, ; Gülhaş et al, ; Kadıoğlu, Tüker, Gurbet, Demirci, & Hülagü, ; Kelsaka, Guldogus, & Cetinoglu, ; Sagiroglu, ; Ozer et al, ). Eight studies utilized DEX 50 mg (Atalay et al, ; Bolat et al, ; Çağiran et al, ; Gelir, ; Gülhaş et al, ; Kadıoğlu et al, ; Kelsaka et al, ; Ozer et al, ), while the remaining studies evaluated DEX 25 mg (Esparza‐Villalpando et al, ; Iohom et al, ; Kara et al, ; Kesimci et al, ; Ozer et al, ; Sagiroglu, ).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…of DEX (Eroglu, Durmus, & Kiresi, ; Esparza‐Villalpando et al, ; Iohom, Walsh, Higgins, & Shorten, ; Kara, Tuncer, Erol, & Reisli, ; Kesimci, Gümüs, & Kanbak, ), while the other studies employed intravenous (i.v.) administration (Atalay, Dogan, & Kizilkaya, ; Bolat, Erhan, & Deniz, ; Çağiran, Eyigör, & Sezer, ; Gelir, ; Gülhaş et al, ; Kadıoğlu, Tüker, Gurbet, Demirci, & Hülagü, ; Kelsaka, Guldogus, & Cetinoglu, ; Sagiroglu, ; Ozer et al, ). Eight studies utilized DEX 50 mg (Atalay et al, ; Bolat et al, ; Çağiran et al, ; Gelir, ; Gülhaş et al, ; Kadıoğlu et al, ; Kelsaka et al, ; Ozer et al, ), while the remaining studies evaluated DEX 25 mg (Esparza‐Villalpando et al, ; Iohom et al, ; Kara et al, ; Kesimci et al, ; Ozer et al, ; Sagiroglu, ).…”
Section: Resultsmentioning
confidence: 99%
“…Nine articles reported this comparison (Atalay et al,; Bolat et al, ; Çağiran et al, ; Gelir, ; Gülhaş et al, ; Iohom et al, ; Kara et al, ; Kesimci et al, ; Kelsaka et al, ). Age of the patients included in these studies ranged from 18 to 85 years.…”
Section: Qualitative Synthesismentioning
confidence: 99%
See 2 more Smart Citations
“…В течение длительного времени декскетопрофен успешно используется не только при стационарном, но и на амбулаторно-поликлиническом этапе лечения паци-ентов, в ортопедии и травматологии [34,37,38,47,48,55,[75][76][77], гинекологии [33,54,[78][79][80][81], общей хирургии [41,42,52,55,82,83], нейрохирургии [39,[84][85][86] и других отраслях медицины [5,56,60].…”
Section: неврологияunclassified